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Spotlight on Research:   
Gary Williams, MD  
It is with greatest pleasure that we would like to congratulate our very own 
Dr. Gary Williams for receiving an Excellence in Science Award from the 
Genetic Toxicology Association at this year’s Annual Meeting at the 
University of Delaware. The Excellence in Science Award is the highest 
award in the Genetic Toxicology Association that is awarded to a member 
for their outstanding contribution to the field of genetic toxicology. 
Dr. Williams has been a major contributor to the study of the genetic effects 
of chemicals. He developed proliferating cultures of rat liver epithelial cell 
lines which were used for 
investigation of the processes  
of cell transformation and 
mutagenesis. Also, he 
developed primary cultures of 
hepatocytes and demonstrated 
their utility for measurement of 
DNA repair as a screening 
method. These advances were 
recognized for their potential to 
reduce animal use by the 
Society of Toxicology with the 
Enhancement of Animal Welfare 
Award in 2002. In the course of this work, he developed the William’s 
Medium E, an extensively used liver cell culture media.  
Recently, he developed the use of avian eggs for assessment of chemical 
genotoxicity using measurement of liver DNA strand breaks and adducts. 
These unique models, named the Chicken and Turkey Egg Genotoxicity 
Assays, allow monitoring of changes in gene expression and histopathology 
in addition to genetic effects.  
Dr. Williams has authored or coauthored over 500 publications. His 
publications have been cited more than 23,000 times as recorded by 
Google Scholar.  In 2006 he was awarded the Dean’s Distinguished 
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  Journal Club Highlight: 
Shamina Sultana, PGY-3 Resident, and Mentor, Dr. Hank Wang (right) 
Optimizing a Metatranscriptomic Next-Generation Sequencing Protocol for 
Bronchoalveolar Lavage Diagnostics 
Compared with conventional serologic, culture-based, and molecular-based diagnostic tests, next-
generation sequencing (NGS) provides sequence-evidenced detection of various microbes, without 
prior knowledge, and thus is becoming a novel diagnostic approach. Herein we describe an RNA-
based metatranscriptomic NGS (mtNGS) protocol for culture-independent detection of potential 
infectious pathogens, using clinical bronchoalveolar lavage specimens as an example. We present 
both an optimized workflow for experimental sequence data collection and a simplified pipeline for 
bioinformatics sequence data processing. As shown, the whole protocol takes approximately 24 to 
36 hours to detect a wide range of Gram-positive and -negative bacteria and possibly other viral 
and/or fungal pathogens. In particular, we introduce a spike-in RNA mix as an internal control, 
which plays a critical role in mitigating false-positive and false-negative results of clinical diagnostic 
tests. Moreover, our mtNGS method can detect antibiotic resistance genes and virulence factors; 
although it may not be comprehensive, such information is imperative and helpful for the clinician 
to make better treatment decisions. Results from our preliminary testing suggest that the mtNGS 
approach is a useful alterative in diagnostic detection of emerging infectious pathogens in clinical 
laboratories. However, further improvements are needed to achieve better sensitivity and accuracy. 
Huang W, Yin C, Wang G, Rosenblum J, Krishnan S, Dimitrova N, Fallon JT. 
Congratulations 
to first author 
Weihua Huang! 
